• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development of novel treatment through the hepatocellular carcinoma (HCC) specific siginaling pathway and molecular based gene expression profiling for advanced HCC

Research Project

Project/Area Number 17390367
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionOsaka University

Principal Investigator

UMESHITA Koji  Osaka University, Hospital, Assistant, 医学部附属病院, 助手 (60252649)

Co-Investigator(Kenkyū-buntansha) NAGANO Hiroaki  Osaka University, Graduate School of Medicine, lecturer, 医学系研究科, 講師 (10294050)
DONO Keizo  Osaka University, Graduate School of Medicine, lecturer, 医学系研究科, 講師 (60283769)
YAMAMOTO Hirofumi  Osaka University, Graduate School of Medicine, Assistant, 医学系研究科, 助手 (30322184)
TAKEMASAO Ichiro  Osaka University, Graduate School of Medicine, Assistant, 医学系研究科, 助手 (50379252)
MONDEN Morito  Osaka University, Graduate School of Medicine, Professor, 医学系研究科, 教授 (00127309)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥14,800,000 (Direct Cost: ¥14,800,000)
Fiscal Year 2006: ¥7,200,000 (Direct Cost: ¥7,200,000)
Fiscal Year 2005: ¥7,600,000 (Direct Cost: ¥7,600,000)
Keywordshepatocellular carcinoma / advanced cancer / portal venous thrombus / IFN-α / chemotherapy / IFN-receptor / angiogenesis / Gene Expression Profiling / IFN併用化学療法 / TRAIL / NK細胞 / Fas / Fas-L / Angiopoietin / 難治性進行癌
Research Abstract

1) The mechanism of the antitumor effect through the IFN-IFNAR signaling
The anti-tumor effect of IFN/5-FU combined therapy was significantly correlated with the strength of IFNAR expression, in the HCC cells in-vitro. In this mechanism, the methylation of IFNAR gene was significantly correlated with anti-tumor effect, among the several factors.
2) Anti tumor effect through the relationship between IFN and 5FU metabolism
In the anti-tumor effect of IFN and 5FU, IFN would induce the TS-1 inhibitory rate in 5FU metabolism.
3) Anti tumor effect through Fas/FasL
Among peripheral blood cells, NK cells were found to exert the cytotoxic effects on human hepatoma cells. In addition, the involvement of CTL system in the anti tumor effect was examined and confirmed in terms of the relationship of apoptosis in this study.
4) Anti tumor effect through the anti-angiogenic action
About the anti-angiogenic action of IFN, Ang-2 was the one of most important factor, among several anti-angiogenic molecules, TSP, Ang-1, VEGF, Tie2, HIF1-α.
5) The Gene Expression Profiling
Using the clinical samples treated by IFN-α and 5-FU, the gene expression profiling would be suggested to be useful for the prediction of the treatment efficacy at the over 85%.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (36 results)

All 2006 2005 Other

All Journal Article (36 results)

  • [Journal Article] TGF-betal-induced cell growth arrest and partial differentiation is related to the suppression of Idl in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B., Nagano H., Kondo M., Natsag J., Hanada H., Nakamura M., Wada H., Kato H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      Oncol Rep 15(2)

      Pages: 401-408

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Angiogenesis in cholangiocellular carcinoma : Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.2006

    • Author(s)
      Tang D., Nagano H., Yamamoto H., Wada H., Nakamura M., Kondo M., Ota H., Yoshioka S., Kato H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Wakasa K., Monden M.
    • Journal Title

      Oncol Rep 15(3)

      Pages: 525-532

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M
    • Journal Title

      Hepatology Research 35

      Pages: 289-295

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma : a comparative study with hepatocellular carcinoma and cholangiocellular carcinom.2006

    • Author(s)
      Tang D., Nagano H., Nakamura M., Wada H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      J Gastronitest Surg 2006 10(7)

      Pages: 987-998

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma : importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.2006

    • Author(s)
      Wada H., Nagano H., Yamamoto H., Yang Y., Kondo M., Ota H., Nakamura M., Yoshioka S., Kato H., Damdinsuren B., Tang D., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Nakamori S., Sakon M., Dono K., Wakasa K., Monden M.
    • Journal Title

      Liver International 26

      Pages: 414-423

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Alpha-fetoprotein mRNA Detection in Peripheral Blood for Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation.2006

    • Author(s)
      Marubashi S., Dono K., Sugita Y., Asaoka T., Hama N., Gotoh K., Miyamoto A., Takeda Y., Nagano H., Umeshita K., Monden M.
    • Journal Title

      Transplant Proc 38(10)

      Pages: 3640-3642

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chmotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-α.2006

    • Author(s)
      Nakamura M., Nagano H., Wada H., Noda T., Ota H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita k., Dono K., Monden M.
    • Journal Title

      J Gastroenterol 10(1007)

      Pages: 1120-1125

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] TGF-betal-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B., Nagano H., Kondo M., Natsag J., Hanada H., Nakamura M., Wada H., Kato H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      Oncol Rep. 15(2)

      Pages: 401-408

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Angiogenesis in cholangiocellular carcinoma : Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.2006

    • Author(s)
      Tang D., Nagano H., Yamamoto H., Wada H., Nakamura M., Kondo M., Ota H., Yoshioka S., Kato H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Wakasa K., Monden M.
    • Journal Title

      Oncol Rep. 15(3)

      Pages: 525-532

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M.
    • Journal Title

      Hepatology Research. 35

      Pages: 289-295

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma : a comparative study with hepatocellular carcinoma and cholangiocellular carcinom.2006

    • Author(s)
      Tang D., Nagano H., Nakamura M., Wada H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      J Gastronitest Surg 10(7)

      Pages: 987-998

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Alpha-fetoprotein mRNA Detection in Peripheral Blood for Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation.2006

    • Author(s)
      Marubashi S., Dono K., Sugita Y., Asaoka T., Hama N., Gotoh K., Miyamoto A., Takeda Y., Nagano H., Umeshita K., Monden M.
    • Journal Title

      Transplant Proc. 38(10)

      Pages: 3640-3642

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chmotherapy with the novel oral DPD- inhibiting chemotherapeutic drug S-1 and interferon-α.2006

    • Author(s)
      Nakamura M., Nagano H., Wada H., Noda T., Ota H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita k., Dono K., Monden M.
    • Journal Title

      J Gastroenterol. 10(1007)

      Pages: 1120-1125

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.2006

    • Author(s)
      Damdinsuren B., Nagano H., Kondo M., Natsag J., Hanada H., Nakamura M., Wada H., Kato H., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Dono K., Monden M.
    • Journal Title

      Oncol Rep 15(2)

      Pages: 401-408

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.2006

    • Author(s)
      Nakamura M, Nagano H, Noda T, Wada H, Ota H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Doki Y, Umeshita K, Dono K, Sakon M, Monden M.
    • Journal Title

      Hepatology Research 35

      Pages: 289-295

    • Related Report
      2006 Annual Research Report
  • [Journal Article] A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chmotherapy with the novel oral DPD- inhibiting chemotherapeutic drug S-1 and interferon-α.2006

    • Author(s)
      Nakamura M., Nagano H., Wada H., Noda T., Ota H., Damdinsuren B., Marubashi S., Miyamoto A., Takeda Y., Umeshita k., Dono K., Monden M.
    • Journal Title

      J Gastroenterol 10(1007)

      Pages: 1120-1125

    • Related Report
      2006 Annual Research Report
  • [Journal Article] TGF-beta1-induced cell growth arrest and partial differentiation is related to suppression of Id1 in some human hepatoma cells.2006

    • Author(s)
      Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    • Journal Title

      Oncology Reports 15(2)

      Pages: 401-408

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Angiogenesis in cholangiocellular carcinoma : Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospodin-1 and clinicopathological significance.2006

    • Author(s)
      Tang D, Nagano H, Yamamoto H, Wada H, Nakamura M, Kondo M, Ota H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Wakasa K, Monden M.
    • Journal Title

      Oncology Reports 15

      Pages: 525-532

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma : A new approach to identify novel tumor markers.2006

    • Author(s)
      Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    • Journal Title

      Int J Oncol 28(2)

      Pages: 383-391

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.2005

    • Author(s)
      Morimoto O., Nagano H., Miyamoto A., Fujiwara Y., Kondo M., Yamamoto T., Ota H., Nakamura M., Wada H., Damdinsuren B., Marubashi S., Dono K., Umeshita K., Nakamori S., Sakon M., Monden M.
    • Journal Title

      Surgery Today 35(12)

      Pages: 1033-1041

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.2005

    • Author(s)
      Morimoto O., Nagano H., Miyamoto A., Fujiwara Y., Kondo M., Yamamoto T., Ota H., Nakamura M., Wada H., Damdinsuren B., Marubashi S., Dono K., Umeshita K., Nakamori S., Sakon M., Monden M.
    • Journal Title

      Surgery Today. 35(12)

      Pages: 1033-1041

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Combination of interferon alpha and 5-fluorouracil induces apoptosis through interferon alpha/beta receptor in human hepatocellular carcinoma cells.2005

    • Author(s)
      Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.
    • Journal Title

      Clinical Cancer Research 11

      Pages: 1277-1286

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Expression of ID proteins in human hepatocellular carcinoma : Relevance to tumor dedifferentiation.2005

    • Author(s)
      Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T, Marubashi S, Miyamoto A, Umeshita K, Dono K, Nakamori S, Wakasa K, Sakon M, Monden M.
    • Journal Title

      Int J Oncol 26

      Pages: 319-327

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Association between tumor recurrence after surgery in patients with hepatocellular carcinoma and measurement of alpha-fetoprotein mRNA in peripheral blood but not bone marrow2005

    • Author(s)
      Morimoto O, Nagano H, Miyamoto A, Fujiwara Y, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.
    • Journal Title

      Surgery Today 35(12)

      Pages: 1033-1041

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Treatment of hepatocellular carcinoma with major portal vein thrombosis by combination of subcutaneous interferon-α and intra-arterial 5-fluorouracil. Role of expression of type 1 interferon receptor2005

    • Author(s)
      Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Nakamura M, Damdinsuren B, Wada H, Marubashi, Miyamoto A, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M
    • Journal Title

      Br J Cancer 93(5)

      Pages: 557-564

    • Related Report
      2005 Annual Research Report
  • [Journal Article] <特集:肝癌、胆道、膵癌に対する治療戦略>肝細胞癌に対する治療方針と治療法の適択について:外科的立場から2005

    • Author(s)
      永野浩昭, 門田守人
    • Journal Title

      FOCUS on ONCOLOGY 3(July)

      Pages: 2-4

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Readers Board,肝癌治療はこれでよいのか-22005

    • Author(s)
      永野浩昭
    • Journal Title

      肝臓 46(3)

      Pages: 149-150

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 進行肝癌に対するインターフェロン併用化学療法と外科治療2005

    • Author(s)
      永野浩昭, 門田守人
    • Journal Title

      消化器科 40(6)

      Pages: 685-691

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 107,Stage IV肺癌の治療と再発予防 特集 肝細胞癌-今日の治療戦略-2005

    • Author(s)
      左近賢人, 永野浩昭, 新居延高宏, 門田守人
    • Journal Title

      外科治療 98(1)

      Pages: 53-58

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 特集 肝臓におけるゲノミクス研究 6.肝細胞癌・化学療法感受性予測-IFN/5FU併用療法の効果予測-2005

    • Author(s)
      黒川幸典, 永野浩昭, 門田守人
    • Journal Title

      肝臓 46(10)

      Pages: 611-615

    • Related Report
      2005 Annual Research Report
  • [Journal Article] IFN(インターフェロン) これだけは知っておきたい癌の免疫化学療法2005

    • Author(s)
      永野浩昭, 門田守人
    • Journal Title

      免疫療法における治療のポイント

      Pages: 163-168

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma : Importance of angiopoietin-2 and hypoxia-induced factor-1□

    • Author(s)
      Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, Nakamura M, Yoshioka S, Kato H, Damdinsuren B, Tang D, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Sakon M, Dono K, Wakasa K, Monden M.
    • Journal Title

      Liver International (in press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Hepatic resection followed by IFN-α and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.

    • Author(s)
      Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Bazarragcha D, Marubashi S, Miyamoto A, Takeda Y, Keizo Dono, Umeshita K, Nakamori S, Monden M
    • Journal Title

      Hepatogastroenterology (in press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Clinical and Pathological Features of Allen's type C of Resected Combined Hepatocellular and Cholangiocarcinoma. A Comparative Study with Hepatocellular Carcinoma and Cholangiocellular Carcinoma

    • Author(s)
      Tang D, Nagano H, Nakamura M, Kondo M, Ota H, Wada H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M
    • Journal Title

      J Gastrointest Surg (in press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.

    • Author(s)
      Arai I, Nagano H, Kendo M, Yamamoto H, Hiraoka N, Sugita Y, Ota H, Yoshioka S, Nakamura M, Wada H, Damdinsuren B, Kato H, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M.
    • Journal Title

      Hepatogastroenterology (in press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Expression of type I Interferon Receptor as a Predictive Marker in Clinical Response of Interferon-α Treatment for Gastrointestinal Cancers

    • Author(s)
      Ota H, Nagano H, Doki Y, Sekimoto M, Kondo M, Wada H, Nakamura M, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M
    • Journal Title

      Oncology Reports (in press)

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi